DE3382112D1 - Pharmazeutische zusammensetzung. - Google Patents

Pharmazeutische zusammensetzung.

Info

Publication number
DE3382112D1
DE3382112D1 DE8383302290T DE3382112T DE3382112D1 DE 3382112 D1 DE3382112 D1 DE 3382112D1 DE 8383302290 T DE8383302290 T DE 8383302290T DE 3382112 T DE3382112 T DE 3382112T DE 3382112 D1 DE3382112 D1 DE 3382112D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8383302290T
Other languages
English (en)
Inventor
Shigeshi Toyoshima
Fukushima Fukushima
Yoshiko Seto
Izumi Kumashiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57073306A external-priority patent/JPS58189121A/ja
Priority claimed from JP6599983A external-priority patent/JPS59190926A/ja
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of DE3382112D1 publication Critical patent/DE3382112D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
DE8383302290T 1982-04-30 1983-04-22 Pharmazeutische zusammensetzung. Expired - Lifetime DE3382112D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57073306A JPS58189121A (ja) 1982-04-30 1982-04-30 インシユリン投与賦活剤
JP6599983A JPS59190926A (ja) 1983-04-14 1983-04-14 吸収性付与剤

Publications (1)

Publication Number Publication Date
DE3382112D1 true DE3382112D1 (de) 1991-02-21

Family

ID=26407159

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383302290T Expired - Lifetime DE3382112D1 (de) 1982-04-30 1983-04-22 Pharmazeutische zusammensetzung.

Country Status (5)

Country Link
US (1) US4670584A (de)
EP (1) EP0093551B1 (de)
CA (1) CA1250090A (de)
DE (1) DE3382112D1 (de)
DK (1) DK170855B1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
DE3674474D1 (de) * 1985-06-08 1990-10-31 Suntory Ltd Phenoxyacetylamidderivate, verfahren zu ihrer herstellung und ihre verwendung.
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
JPH0791251B2 (ja) * 1987-11-20 1995-10-04 味の素株式会社 フェニルアラニン誘導体及びその用途
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US20020042377A1 (en) * 1995-06-07 2002-04-11 Steiner Joseph P. Rotamase enzyme activity inhibitors
JP4273662B2 (ja) * 1999-04-26 2009-06-03 味の素株式会社 メラノサイト刺激ホルモン阻害剤
US6878749B2 (en) * 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
EP1265638A1 (de) * 1999-11-12 2002-12-18 Pharmaderm Laboratories Ltd. Arzneizubereitungen zur transdermalen oder transmucosalen verabreichung von wirkstoffen
JP4158192B2 (ja) * 2000-10-18 2008-10-01 味の素株式会社 アシルフェニルアラニンの製造方法
FR2828102B1 (fr) * 2001-03-28 2004-07-09 Ifc Sa Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes
GB2389582A (en) * 2002-06-13 2003-12-17 Bayer Ag Pharmaceutically active carboxamides
MX360107B (es) 2012-11-13 2018-10-23 Adocia Formulación de acción rápida de insulina que comprende un compuesto aniónico sustituido.
FR3020947B1 (fr) * 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) * 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
WO2017084696A1 (fr) * 2015-11-16 2017-05-26 Adocia Composition a action rapide d'insuline comprenant un compose anionique substitue et un compose polyanionique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5123056B2 (de) * 1972-04-03 1976-07-14
IL46207A0 (en) * 1974-12-09 1975-03-13 Technion Res & Dev Foundation Process for the direct manufacture of acyl derivatives of aromatic alpha-amino acids
DE3003898A1 (de) * 1980-02-02 1981-08-13 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur acylierung von aminocarbonsaeuren
FR2509175B1 (fr) * 1981-03-06 1987-01-16 Toyo Jozo Kk Preparation therapeutique ayant d'excellentes proprietes d'absorption

Also Published As

Publication number Publication date
EP0093551B1 (de) 1991-01-16
DK170855B1 (da) 1996-02-12
DK192583D0 (da) 1983-04-28
CA1250090A (en) 1989-02-14
EP0093551A2 (de) 1983-11-09
DK192583A (da) 1983-10-31
US4670584A (en) 1987-06-02
EP0093551A3 (en) 1985-11-21

Similar Documents

Publication Publication Date Title
DE3486255T2 (de) Pharmazeutische Zusammensetzungen.
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
ATE22007T1 (de) Pharmazeutische mischung.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
DE3586545D1 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE3576117D1 (de) Mehrphasige pharmazeutische zusammensetzung.
ATE59286T1 (de) Pharmazeutische mixtur.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
FI893643A (fi) Farmaceutiska kompositioner.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
FI872733A (fi) Farmaceutiska kompositioner.
FI872313A0 (fi) Farmaceutiska kompositioner.
FI883673A0 (fi) Farmaceutiska kompositioner.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
IT1213453B (it) Composizione farmaceutica.
ATE36455T1 (de) Pharmazeutische zusammensetzungen.
DE3483900D1 (de) Pharmazeutische zusammensetzungen.
FI831687L (fi) Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
DE68907609D1 (de) Arzneimittelzusammensetzung.
NL193821B (nl) Farmaceutisch preparaat.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee